Don’t lose sight of M. hyo while battling other swine pathogens
Jan 28, 2019Susan Spiegel
TOOLBOX, Issue 1: An interview with
Lucina Galina Pantoja, DVM, PhD,
Director, Swine Technical Services,
Zoetis
Long duration of antibiotic helps improve clinical outcome after APP challenge
Jan 14, 2019Susan Spiegel
DISCOVERIES, Issue 10: Pigs treated with one intramuscular dose of Draxxin® (tulathromycin) and then challenged with a virulent strain of APP had significantly reduced mortality and lung lesions...
Chimera technology offers better path to protection for PCV2
Nov 12, 2018Susan Spiegel
When PCV2 first became a problem in US swine herds, scientists looked at taking the immunogenic capsid gene from PCV2 and cloning it into the backbone of nonpathogenic PCV type 1 to produce a live...
Five steps to better Mycoplasma hyopneumoniae control
Oct 17, 2018PGT Editor
For pig producers and veterinarians, the health and economic impact of Mycoplasma hyopneumoniae is clear. In the US, enzootic pneumonia caused by M. hyo is considered one of the “big three”...
M. hyo: Control or elimination?
Jun 05, 2017Susan Spiegel
Effective control of Mycoplasma hyopneumoniae (M. hyo) has to start in the breeding herd to prevent problems with the disease in finishers, according to Lucina Galina, DVM, director of technical...
Proposed classification system to improve M. hyo control tested in commercial setting
May 19, 2017Susan Spiegel
By Lucina Galina Pantoja, DVM, PhD, Director, swine technical services, Zoetis
